Loading insider details...
Beta
Latest Form 4 (Aug 5, 2026): Grant/Award of 37,653 OBX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 5, 2026 | Obsidian Therapeutics, Inc. (OBX) | Grant/Award | 37,653 | n/a |
| May 1, 2026 | Vericel Corp (VCEL) | Exercise/Conversion | 3,200 | n/a |
| Mar 25, 2026 | Vericel Corp (VCEL) | Exercise/Conversion | 15,000 | $41.4K |
| May 2, 2025 | Vericel Corp (VCEL) | Exercise/Conversion | 3,200 | n/a |
| Mar 5, 2025 | Vericel Corp (VCEL) | Exercise/Conversion | 9,000 | $33.7K |
| Oct 21, 2024 | Vericel Corp (VCEL) | Exercise/Conversion | 4,000 | $15.0K |
| May 3, 2024 | Vericel Corp (VCEL) | Exercise/Conversion | 3,200 | n/a |
| May 5, 2023 | Vericel Corp (VCEL) | Grant/Award | 8,000 | n/a |
| Apr 28, 2023 | Vericel Corp (VCEL) | Exercise/Conversion | 2,600 | n/a |
| Apr 29, 2022 | Vericel Corp (VCEL) | Exercise/Conversion | 2,600 | n/a |